Ascendis Pharma
ASND
$145.23
Share price
-0.55%
Change (1 day)
75.48%
Change (1 year)
Categories
Ascendis Pharma (ASND) - Cash on Hand
Cash on Hand as of December 2023 : $0.44 B
According to Ascendis Pharma
's latest financial reports the company has $0.44 B in cash and cash equivalents.
A company’s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
Ascendis Pharma - Cash on Hand chart (from 2013 to 2023)
Cash on Hand by year
| Year | Cash on Hand | Change |
|---|---|---|
| 2023-12-31 | $0.44 B | -43.93% |
| 2022-12-31 | $0.78 B | 1.97% |
| 2021-12-31 | $0.77 B | -12.63% |
| 2020-12-31 | $0.88 B | 31.95% |
| 2019-12-31 | $0.67 B | 110.78% |
| 2018-12-31 | $0.31 B | 35.54% |
| 2017-12-31 | $0.23 B | 23.54% |
| 2016-12-31 | $0.18 B | 45.1% |
| 2015-12-31 | $0.13 B | 114.42% |
| 2014-12-31 | $61.01 M | 127.38% |
| 2013-12-31 | $26.83 M | 39.56% |
| 2012-12-31 | $19.22 M | -5.41% |
| 2011-12-31 | $20.32 M |
Cash on Hand for similar companies or competitors
| Company | Cash on Hand | differencediff. | Country |
|---|---|---|---|
 Akebia Therapeutics AKBA | $42.92 M | -90.28% | 🇺🇸 USA |
 Affimed
AFMD | $0.10 B | -76.68% | 🇩🇪 Germany |
 Advaxis ADXS | $2.12 M | -99.52% | 🇺🇸 USA |